Corcept Therapeutics Inc
CORT· Nasdaq
Released Feb 28, 2023, after the close
10-K filed Feb 28, 2023, 59 days after period end · 0001628280-23-005581
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Revenue | $103.06M | $98.82M | $85.74M | $87.90M |
| Net Income | $16.60M | $32.05M | $25.99M |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $29.38M |
| EPS Diluted | — | — | $0.20 | $0.24 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.